Jushi Holdings Inc. (OTC:JUSH)
| Market Cap | $77.89M-27.8% |
| Revenue (ttm) | $276.54M+6.2% |
| Net Income | -$54.79M+16.4% |
| EPS | -$0.27+18.0% |
| Shares Out | 199.71M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 180,242 |
| Open | $0.41 |
| Previous Close | $0.39 |
| Day's Range | $0.39 - $0.42 |
| 52-Week Range | $0.34 - $0.91 |
| Beta | 1.03 |
| Analysts | Buy |
| Price Target | $1.93(+394.87%) |
| Earnings Date | Apr 21, 2027 |
About JUSH
Jushi Holdings Inc. engages in the retail, distribution, cultivation, and processing of cannabis for medical and adult-use markets in the United States. The company offers flower, vapes, concentrates, infused chews and chocolates, tinctures, capsules, softgels, topicals and RSO, pre-rolls, and infused chocolate bites under the Hijinks, The Bank, The Lab, Tasteology, Uncommon Kind, Nira + Medicinals, Sèche, Shayo, and Carm's Delight Bites brands. It also engages in the sale of bulk raw materials to duly licensed third parties for use in its own finished products. In addition, the company operates medical cannabis dispensaries under the Beyond Hello, Nature's Remedy, and NuLeaf brands. It serves small local dispensaries and large multi-state operators. Jushi Holdings Inc. was founded in 2018 and is headquartered in Boca Raton, Florida.
Jushi Holdings Inc. Stock Analysis — InsiderScore
Jushi Holdings Inc. scored higher than 81% of companies evaluated by InsiderBuying, and ranked 15th out of 94 stocks in the biotech sector.
Scores are percentile-ranked against every company we scored that day, with extra weight given to the size and conviction of each purchase and the seniority of the buyer.
Insiders at Jushi Holdings Inc. bought $1.02 million of stock across 9 purchases in the last 90 days, the largest of them $247.0K.
The average purchase added about 6% to the buyer's existing holding. Doubling a stake earns full marks here; topping up an already large position earns very little.
Every buyer already held stock, so each purchase is an increase rather than a first position.
This category carries 35% of the Insider Score.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Next catalysts
- Apr 21, 2027Earnings report
$JUSH stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in JUSH holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by JUSH's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
JUSH Estimated quarterly lobbying spending
Source: U.S. Senate LDA
JUSH Revenue by Segment
| Retail | $60.81M | 86.28% |
| Wholesale | $9.67M | 13.72% |
As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New JUSH patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to JUSH from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in JUSH
| MSOSAdvisorShares Pure US Cannabis ETF | $12.94M |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from JUSH’s recent data — informational, not investment advice
What’s Behind the Score
Recent Insider Activity
Insider Score Trend Over Time
-7.3 since Sep 15Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.
Frequently Asked Questions
ETFs that hold this stock
| MSOS | AdvisorShares Pure US Cannabis ETF | 1.11% |
Weight is the stock’s share of each fund’s holdings.